These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 27931265)
1. Increased Caspase-6 activity in the human anterior olfactory nuclei of the olfactory bulb is associated with cognitive impairment. Foveau B; Albrecht S; Bennett DA; Correa JA; LeBlanc AC Acta Neuropathol Commun; 2016 Dec; 4(1):127. PubMed ID: 27931265 [TBL] [Abstract][Full Text] [Related]
2. Caspase-6 activity predicts lower episodic memory ability in aged individuals. Ramcharitar J; Afonso VM; Albrecht S; Bennett DA; LeBlanc AC Neurobiol Aging; 2013 Jul; 34(7):1815-24. PubMed ID: 23402898 [TBL] [Abstract][Full Text] [Related]
3. Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits. Noël A; Foveau B; LeBlanc AC Cell Death Dis; 2021 Mar; 12(3):227. PubMed ID: 33649324 [TBL] [Abstract][Full Text] [Related]
4. Activation of caspase-6 in aging and mild cognitive impairment. Albrecht S; Bourdeau M; Bennett D; Mufson EJ; Bhattacharjee M; LeBlanc AC Am J Pathol; 2007 Apr; 170(4):1200-9. PubMed ID: 17392160 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. Ramcharitar J; Albrecht S; Afonso VM; Kaushal V; Bennett DA; Leblanc AC J Neuropathol Exp Neurol; 2013 Sep; 72(9):824-32. PubMed ID: 23965742 [TBL] [Abstract][Full Text] [Related]
6. White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment. Guzman VA; Carmichael OT; Schwarz C; Tosto G; Zimmerman ME; Brickman AM; Alzheimers Dement; 2013 Oct; 9(5 Suppl):S124-31. PubMed ID: 23375566 [TBL] [Abstract][Full Text] [Related]
7. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Giannakopoulos P; Herrmann FR; Bussière T; Bouras C; Kövari E; Perl DP; Morrison JH; Gold G; Hof PR Neurology; 2003 May; 60(9):1495-500. PubMed ID: 12743238 [TBL] [Abstract][Full Text] [Related]
8. The unfolded protein response is activated in the olfactory system in Alzheimer's disease. Murray HC; Dieriks BV; Swanson MEV; Anekal PV; Turner C; Faull RLM; Belluscio L; Koretsky A; Curtis MA Acta Neuropathol Commun; 2020 Jul; 8(1):109. PubMed ID: 32665027 [TBL] [Abstract][Full Text] [Related]
9. Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. Kaushal V; Dye R; Pakavathkumar P; Foveau B; Flores J; Hyman B; Ghetti B; Koller BH; LeBlanc AC Cell Death Differ; 2015 Oct; 22(10):1676-86. PubMed ID: 25744023 [TBL] [Abstract][Full Text] [Related]
10. Caspase-6 as a novel early target in the treatment of Alzheimer's disease. LeBlanc AC Eur J Neurosci; 2013 Jun; 37(12):2005-18. PubMed ID: 23773070 [TBL] [Abstract][Full Text] [Related]
11. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J; Jellinger KA Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156 [TBL] [Abstract][Full Text] [Related]
12. Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon4. Tsuboi Y; Wszolek ZK; Graff-Radford NR; Cookson N; Dickson DW Neuropathol Appl Neurobiol; 2003 Oct; 29(5):503-10. PubMed ID: 14507342 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia. Buchman AS; Leurgans SE; Kim N; Agrawal S; Oveisgharan S; Zammit AR; VanderHorst V; Nag S; Bennett DA J Alzheimers Dis; 2023; 96(2):563-578. PubMed ID: 37840485 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of Nlrp1 inflammasome, Caspase-1, or Caspase-6 against Alzheimer disease cognitive impairment. Flores J; Noël A; Fillion ML; LeBlanc AC Cell Death Differ; 2022 Mar; 29(3):657-669. PubMed ID: 34625662 [TBL] [Abstract][Full Text] [Related]
15. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033 [TBL] [Abstract][Full Text] [Related]
16. Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures. Sivananthan SN; Lee AW; Goodyer CG; LeBlanc AC Cell Death Dis; 2010 Nov; 1(11):e100. PubMed ID: 21368865 [TBL] [Abstract][Full Text] [Related]
17. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration. Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623 [TBL] [Abstract][Full Text] [Related]
18. Early Alzheimer-type lesions in cognitively normal subjects. Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845 [TBL] [Abstract][Full Text] [Related]
20. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia. Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]